Skip to content

Clinical trials

Phase 3 Lymphoma, Large B-Cell, Diffuse trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 3 Country / region: Czechia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20091
20101
20113
20132
20152
20171
20203
20211
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting8
Terminated2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Genmab2
Hoffmann-La Roche2
Incyte Corporation2
Janssen Research & Development, LLC2
ADC Therapeutics S.A.1
Acerta Pharma BV1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
CTI BioPharma1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse23
Lymphoma8
Lymphoma, Non-Hodgkin7
Lymphoma, Follicular5
Recurrence5
Lymphoma, B-Cell4
Neoplasms4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large-Cell, Immunoblastic3
Lymphoma, Mantle-Cell3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.